Paper2938014
Induction of tolerance by monoclonal antibody therapy.
Benjamin RJ and 1 other. Nature, 1986. Cited by 322 papers, by iCite.
Cite this record
ConductScience Library. Induction of tolerance by monoclonal antibody therapy. Papers, record 2938014. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2938014
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal | Major topic |
| Antigens, Surface | Major topic |
| Immunosuppression Therapy | Major topic |
| T-Lymphocytes, Helper-Inducer | Major topic |
| Animals | |
| Antibodies, Anti-Idiotypic | |
| Antigens, Differentiation, T-Lymphocyte | |
| Mice |
Source PubMed
Cited by59
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 322 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38843866 | Unlocking Transplant Tolerance with Biomaterials. | Adv Healthc Mater | 2025 | https://conductscience.org/library/papers/38843866 | PubMed |
| 35774800 | A Recombinant MVA-Based RSV Vaccine Induces T-Cell and Antibody Responses That Cooperate in the Protection Against RSV Infection. | Front Immunol | 2022 | https://conductscience.org/library/papers/35774800 | PubMed |
| 35529847 | Transplant Tolerance, Not Only Clonal Deletion. | Front Immunol | 2022 | https://conductscience.org/library/papers/35529847 | PubMed |
| 32397343 | The Role of TNFR2 and DR3 in the In Vivo Expansion of Tregs in T Cell Depleting Transplantation Regimens. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32397343 | PubMed |
| 31713816 | Molecular Approaches for the Treatment of Pompe Disease. | Mol Neurobiol | 2020 | https://conductscience.org/library/papers/31713816 | PubMed |
| 29165614 | Long-term health in recipients of transplanted in vitro propagated spermatogonial stem cells. | Hum Reprod | 2018 | https://conductscience.org/library/papers/29165614 | PubMed |
| 26865713 | Transient CD4+ T Cell Depletion Results in Delayed Development of Functional Vaccine-Elicited Antibody Responses. | J Virol | 2016 | https://conductscience.org/library/papers/26865713 | PubMed |
| 26110047 | Apoptotic cell-linked immunoregulation: implications for promoting immune tolerance in transplantation. | Cell Biosci | 2015 | https://conductscience.org/library/papers/26110047 | PubMed |
| 25382056 | Enhanced efficacy from gene therapy in Pompe disease using coreceptor blockade. | Hum Gene Ther | 2015 | https://conductscience.org/library/papers/25382056 | PubMed |
| 24691478 | Harnessing FOXP3+ regulatory T cells for transplantation tolerance. | J Clin Invest | 2014 | https://conductscience.org/library/papers/24691478 | PubMed |
| 24151492 | Interleukin 35: a key mediator of suppression and the propagation of infectious tolerance. | Front Immunol | 2013 | https://conductscience.org/library/papers/24151492 | PubMed |
| 22988034 | Foxp3 expression is required for the induction of therapeutic tissue tolerance. | J Immunol | 2012 | https://conductscience.org/library/papers/22988034 | PubMed |
| 22719741 | Boosting regulatory T cell function by CD4 stimulation enters the clinic. | Front Immunol | 2012 | https://conductscience.org/library/papers/22719741 | PubMed |
| 22205213 | The battle against immunopathology: infectious tolerance mediated by regulatory T cells. | Cell Mol Life Sci | 2012 | https://conductscience.org/library/papers/22205213 | PubMed |
| 21716299 | Successful attenuation of humoral immunity to viral capsid and transgenic protein following AAV-mediated gene transfer with a non-depleting CD4 antibody and cyclosporine. | Gene Ther | 2012 | https://conductscience.org/library/papers/21716299 | PubMed |
| 21593400 | Functional regulatory T cells produced by inhibiting cyclic nucleotide phosphodiesterase type 3 prevent allograft rejection. | Sci Transl Med | 2011 | https://conductscience.org/library/papers/21593400 | PubMed |
| 20717099 | Tolerance: an overview and perspectives. | Nat Rev Nephrol | 2010 | https://conductscience.org/library/papers/20717099 | PubMed |
| 19943950 | Protective versus pathogenic anti-CD4 immunity: insights from the study of natural resistance to HIV infection. | J Transl Med | 2009 | https://conductscience.org/library/papers/19943950 | PubMed |
| 18777090 | Regulation and privilege in transplantation tolerance. | J Clin Immunol | 2008 | https://conductscience.org/library/papers/18777090 | PubMed |
| 18701498 | Modulation of protective T cell immunity by complement inhibitor expression on tumor cells. | Cancer Res | 2008 | https://conductscience.org/library/papers/18701498 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2938014
GET https://conductscience.org/api/papers/v1/2938014/cited_by?page=2